Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2001-04-06

Original market date: See footnote 1

1993-12-31

Product name:

TRIAMINIC EXPECTORANT DH SYRUP

DIN:

01906615 Electronic product monograph is not available

Company:

NOVARTIS CONSUMER HEALTH CANADA INC.
500 7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Syrup

Route(s) of administration:

Oral

Number of active ingredient(s):

5

Schedule(s):

Narcotic (CDSA I)

 

American Hospital Formulary Service (AHFS): See footnote 3

48:08.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS

Active ingredient group (AIG) number:See footnote5

0503200001

List of active ingredient(s)
Active ingredient(s) Strength
GUAIFENESIN 100 MG / 5 ML
HYDROCODONE BITARTRATE 1.67 MG / 5 ML
PHENIRAMINE MALEATE 6.25 MG / 5 ML
PHENYLPROPANOLAMINE HYDROCHLORIDE 12.5 MG / 5 ML
PYRILAMINE MALEATE 6.25 MG / 5 ML
Version 4.0.2
Date modified: